Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Breast Neoplasms 2Anorexia 2Depressive Disorder, Major 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Advanced Cancer 1

Interventions

Megestrol Acetate 6Standard of Care 3Exercise 3Physical Therapy Modalities 2Nutrition Assessment 2Infliximab 2Blood Specimen Collection 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1irinotecan sucrosofate 1clazakizumab 1bermekimab 1anamorelin 1Sodium Chloride 1Radiotherapy 1Preoperative Exercise 1Powders 1Pentoxifylline 1Olanzapine 1Nandrolone Decanoate 1Mirtazapine 1Melatonin 1Megestrol 1Immunologic Techniques 1Ibuprofen 1High-Energy Shock Waves 1Ghrelin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cachexia × Mirtazapine × Clear all
NCT03283488 2023-07-07

Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

University of Sao Paulo

Phase 2 Completed
52 enrolled

Anorexia, Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡